FactSet Research Systems (FDS) Expands Private Markets Push As Valuation Questions Linger

Date:

FactSet Research Systems (FDS) has expanded its private markets toolkit by partnering with Nasdaq Private Market to feed verified Cap Table data into its platform for deeper insight into private company ownership and capital structures.

Recent price action has picked up for FactSet Research Systems, with a 7 day share price return of 9.83% and a 30 day gain of 21.33%, building on a 16.29% share price return year to date, even though the 3 year total shareholder return declined 18.24% and the 5 year total shareholder return fell 21.22%.

Spot fresh momentum stories like FactSet Research Systems by scanning our curated list of 21 high quality undiscovered gems, which combines strong fundamentals with under-the-radar profiles.

Bulls view FactSet Research Systems’ private markets expansion and recent share price increase as a reset, while bears highlight longer term underperformance. Which side does the valuation math support next?

Most Popular Narrative: 28% Overvalued

FactSet Research Systems last closed at $331.32, while the most followed valuation story on Simply Wall St pegs fair value at $258.69. This implies the share price sits well above that narrative estimate and places extra weight on how management actions align with the story.

FactSet closed fiscal 2026, with the largest single ASV quarter in its history, $86 million in one period, a 7% full-year organic growth rate above the high end of its own guidance, and language calibrated to signal that the compression chapter is closed. What management presents this morning is not a company celebrating a record. It is a company selecting, with some care, which parts of the record to carry forward, and which commitments from the prior call to quietly retire.

See why 1 investors see FactSet Research Systems as 28% overvalued.

Result: Fair Value of $258.69 (OVERVALUED)

Still, the FactSet Research Systems story could be tested if AI partnerships continue to fade from view or if consumption-based pricing adds more variability to earnings forecasts.

Find out about the key risks to this FactSet Research Systems narrative.

Another View: Multiples Point A Different Way

The narrative fair value of $258.69 paints FactSet Research Systems as 28% overvalued at $331.32. The P/E picture is more mixed. FDS trades on 21.9x earnings, below a peer average of 23.8x and far below the US Capital Markets group at 38.1x, yet above a fair ratio of 14.7x that the market could move toward over time.

This split view means the share price screens cheaper than many peers while still carrying valuation risk if earnings stumble or sentiment cools. Which signal do you weigh more heavily: the relative discount, or the gap to that lower fair ratio that could act as a gravity point for the multiple the next time the story is tested?

See what the numbers say about this price — find out in our valuation breakdown.

NYSE:FDS P/E Ratio as at Oct 2026
NYSE:FDS P/E Ratio as at Oct 2026

Next Steps

Sentiment around FactSet Research Systems is split, with clear concerns sitting beside real optimism. Move quickly, review the underlying data, and weigh the 3 key rewards and 1 important warning sign.

Looking For More Ideas Beyond FactSet Research Systems?

Do not stop with FactSet Research Systems when the next opportunity could already be on your radar. Broaden your watchlist now and keep your options open.

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

Companies discussed in this article include FDS.

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email [email protected]

Share post:

Subscribe

Popular

More like this
Related

UK to invest £100m in ‘world first’ AI Biosecurity Lab

The UK says it will establish a national AI...

Brewers’ Jacob Misiorowski sets World Series velocity record

MILWAUKEE — Jacob Misiorowski broke the record for fastest...

The great moth revival: how bogongs have bounced back | Insects

If you live anywhere on the eastern side of...